Evidence map›Paper›PMID 35368518›Full record

ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2022

Point Prevalence Surveys of Antimicrobial Prescribing in a Non-Acute Care Hospital in Saitama Prefecture, Japan.

Noriomi Ishibashi, Ines Pauwels, Yuki Tomori, Yoshiaki Gu, Takefumi Yamaguchi, Takahiro Handa, Minoru Yamaoka, Daisuke Ito, Takehiko Sakimoto, Takuma Kimura and 9 more

Open access · goldAbstract read
In one paragraph

Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Three-Year Point Prevalence Survey of Antimicrobial Use in a Chinese University Hospital.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Noriomi Ishibashi *Department of Infectious Disease and Infection Control, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.ORCID https://orcid.org/0000-0002-5718-7596
Ines Pauwels *Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, Faculty of Medicine and Health Science, University of Antwerp, Universiteitsplein, Universiteitsplein 1, 2610 Wilrijk, Belgium.
Yuki TomoriDepartment of Internal Medicine, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Yoshiaki GuDepartment of Infectious Diseases, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo, Tokyo 113-8510, Japan.ORCID https://orcid.org/0000-0003-2509-1052
Takefumi YamaguchiDepartment of Internal Medicine, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Takahiro HandaDepartment of Internal Medicine, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Minoru YamaokaDepartment of Internal Medicine, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Daisuke ItoDepartment of Internal Medicine, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Takehiko SakimotoDepartment of Internal Medicine, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Takuma KimuraDepartment of Internal Medicine, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Kouichi TakizawaDepartment of Internal Medicine, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Ryota SatoDepartment of Pharmacy, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Takahiro SakashitaDepartment of Pharmacy, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Akira OoyamaDepartment of Pharmacy, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Ann VersportenLaboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, Faculty of Medicine and Health Science, University of Antwerp, Universiteitsplein, Universiteitsplein 1, 2610 Wilrijk, Belgium.
Herman GoossensLaboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, Faculty of Medicine and Health Science, University of Antwerp, Universiteitsplein, Universiteitsplein 1, 2610 Wilrijk, Belgium.
Norihito TarumotoDepartment of Infectious Disease and Infection Control, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Shigefumi MaesakiDepartment of Infectious Disease and Infection Control, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Norio TanahashiDepartment of Internal Medicine, Maruki Memorial Medical and Social Welfare Center, 38 Morohongo, Moroyama, Iruma-gun, Saitama 350-0495, Japan.
Saitama Medical University · JPUniversity of Antwerp · BESocial Insurance Saitama Chuo Hospital · JPTokyo Medical and Dental University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The global point prevalence survey (Global-PPS) is the standard for the surveillance of prescribed antimicrobials among inpatients and provides data for the development of hospital antimicrobial stewardship programs. Aim: To evaluate the prevalence and quality of antimicrobial prescriptions using the universally standardized Global-PPS protocol in a non-acute care hospital in Saitama Prefecture, Japan. Methods: Antimicrobial prescriptions for inpatients, staying at the hospital overnight, were surveyed on three separate week days in November 2018, January 2019, and May 2019. Information on the prescribed antimicrobials on the survey target day was obtained from the in-hospital pharmacy. Survey data were collected by physicians, based on the extracted information. Patient information was anonymized and entered in the Global-PPS Web application by physicians. We report the antimicrobial use prevalence, the indication for prescription, diagnosis, the most prescribed antimicrobials, and a set of quality indicators related to antimicrobial prescribing. Results: In total, 6.7% of the surveyed inpatients (120/1796) were prescribed antimicrobials on the survey day. Sulfamethoxazole/trimethoprim was the most commonly prescribed, with 20.0% of systemic antibiotic prescriptions (ATC J01). Of all antibiotics for systemic use, up to 58.4% were Watch antibiotics, as defined by the World Health Organization AWaRe classification. The most prescribed group of systemic antibiotics was non-penicillin beta-lactam antibiotics (34.4%), followed by penicillin antibiotics in combination with beta-lactamase inhibitors (25.6%), and sulfonamides with trimethoprim (20.8%). Healthcare-associated infections and medical prophylaxis were the most common indications reported in 69.3% and 26.3% of prescriptions, respectively. The most common diagnosis for systemic antibiotic prescriptions was pneumonia (49.6%). Reasons for antimicrobial prescriptions were indicated in the medical records for 67.1% of prescriptions, and the stop/review date was documented to be 50.3%. Compliance with local guidelines reached 66.7%. Conclusions: This study highlights important challenges related to antimicrobial prescription in a highly specific, non-acute care patient population.

Identifiers

PMID35368518
PMCPMC8975653
OpenAlexW4220979541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.